Vise Technologies’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$522K Sell
4,891
-1,423
-23% -$172K 0.01% 1127
2026
Q1
$1.1M Hold
6,314
– – 0.02% 557
2025
Q4
$1.1M Buy
6,314
+982
+18% +$179K 0.02% 561
2025
Q3
$768K Sell
5,332
-468
-8% -$57.3K 0.03% 502
2025
Q2
$584K Buy
+5,800
New +$443K 0.02% 584
2024
Q4
$389K Buy
5,634
+336
+6% +$24.2K 0.03% 505
2024
Q3
$387K Sell
5,298
-1,208
-19% -$89.1K 0.05% 370
2024
Q2
$436K Buy
+6,506
New +$252K 0.08% 250
2024
Q1
– Sell
-8,050
Closed -$249K – 387
2023
Q4
$249K Buy
+8,050
New +$209K 0.05% 302

Other funds holding INSM

Vise Technologies's INSM Position: Q2 2026 in Review

Vise Technologies reduced its Insmed (INSM) stake by 23% in Q2 2026, selling an estimated $172K and leaving 4,891 shares worth $522K. The position accounts for 0.01% of the portfolio, ranked #1127.

Vise Technologies first reported a position in INSM in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.1M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Vise Technologies held 4,891 shares of Insmed worth $522K as of Q2 2026.
  • Vise Technologies sold 1,423 Insmed shares in Q2 2026, an estimated $172K.
  • Insmed made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #1127 holding.
  • Vise Technologies first reported a position in Insmed in Q4 2023 and has held it in 9 quarters since.
  • Vise Technologies's Insmed position peaked at $1.1M in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.